Life Sciences Executive Series – CFO | Deloitte US has been added to your bookmarks.
Transactions and Operations for the Life Sciences CFO
Life Sciences Executive Series
The CFO series is designed to provide quick access to critical industry trends and issues CFOs face. Click the link below to access the most recent research. This page will be updated with additional content as new data becomes available.
M&A drives shareholder value for life sciences
As CFOs of life sciences companies are increasingly expected to participate in shareholder value creation, they should consider broadening their role in driving corporate strategy, including creative approaches to mergers, acquisitions, and restructurings.